Cargando…
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
CTL with optimal effector function play critical roles in mediating protection against various intracellular infections and cancer. However, individuals may exhibit suppressive immune microenvironment and, in contrast to activating CTL, their autologous antigen presenting cells may tend to tolerize...
Autores principales: | Chiu, Yen-Ling, Schneck, Jonathan P., Oelke, Mathias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169282/ https://www.ncbi.nlm.nih.gov/pubmed/21505415 http://dx.doi.org/10.3791/2801 |
Ejemplares similares
-
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
por: Schütz, Christian, et al.
Publicado: (2014) -
Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy
por: Perica, Karlo, et al.
Publicado: (2014) -
Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression
por: Israeli, Moshe, et al.
Publicado: (2014) -
Wnt pathway activation functionally reprograms human antigen-specific T cells
por: Chiu, Yen-Ling, et al.
Publicado: (2014) -
Forward Vaccinology: CTL Targeting Based upon Physical Detection of HLA-Bound Peptides
por: Reinherz, Ellis L., et al.
Publicado: (2014)